Intel heads into the week of June 22 with a familiar but sharpening tension: the stock just pulled back 6.1% on Tuesday to close at $132.28, yet BofA's Vivek Arya raised his price target to $160 the same morning — pushing the most bullish target on the board even further above a consensus mean of $94.75.
The valuation gap is now wider than at any point in recent memory. Intel trades at a 40% premium to the mean analyst target, a figure that has barely budged despite a string of target raises since June 1. Arya's $160 target is the most aggressive on the board; Barclays and Wells Fargo sit at $100 and $110 respectively, both maintaining neutral-equivalent ratings. Mizuho is at $128 with a Neutral. The picture is one of bulls raising numbers fast while the neutral camp acknowledges the move but stops short of endorsing the price. The P/E multiple has expanded to roughly 103x trailing earnings and the P/B to 5.3x — both up sharply over 30 days. EV/EBITDA at 31x is compressing slightly as consensus earnings estimates drift higher, but the 90-day EPS momentum factor ranks in the 99th percentile of the ORTEX universe. The Street is upgrading its numbers; it is not yet upgrading its conviction on the price.
The short book tells a much quieter story. Short interest is only 2.75% of the free float — a genuinely low level — and has barely moved on the week, up about 2.8% in shares but with no meaningful directional signal. Availability in the lending market is effectively unlimited, consistent with prior readings. Borrowing cost edged up to 0.55%, a six-week high but still firmly in "cheap to short" territory. These are not the mechanics of a squeeze, nor of a conviction short. The borrow market is simply indifferent to the foundry narrative playing out in the equity. Options tell a mildly different story: the put/call ratio has dropped to 0.99, more than a standard deviation below its 20-day average of 1.01, meaning call activity has been running relatively hot. That's consistent with traders reaching for upside exposure on successive foundry headlines rather than hedging into the July 23 earnings date.
The institutional ownership picture adds one notable data point. BlackRock added approximately 15.3 million shares in the month through May 31, bringing its stake to 8.9% of the company. Capital Research added 26.7 million shares through late May. FMR (Fidelity) added 26.7 million. These are not passive rebalancing moves — they are active accumulations concurrent with the foundry-catalyst rally. Against that, the CFO sold $2 million of stock on June 1 at around $110, and an executive vice president sold $2.5 million at $118 in late May. Those sales happened below the current price, and the 90-day net insider position is technically positive thanks to award grants — but the selling cadence from management-level insiders into the rally is worth noting alongside the institutional buying.
The earnings print on July 23 now dominates the near-term calendar. The last release, in April, produced a 26% single-day gain and a 45% five-day move — the foundry-catalyst repricing in its most dramatic form. The subsequent May release produced a 3.9% decline. With the stock now running well above every neutral analyst target, the July 23 print becomes less about whether Intel is growing and more about whether the foundry pipeline converts into something the earnings model can capture — because at 103x earnings, the market is already pricing in a version of that story.
See the live data behind this article on ORTEX.
Open INTC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
